| Code | CSB-RA011661MB9HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to SSGJ-611, targeting the interleukin-4 receptor (IL4R), a type I transmembrane protein critical for mediating immune responses. IL4R forms receptor complexes that bind both IL-4 and IL-13, initiating JAK-STAT6 signaling pathways that regulate T helper 2 (Th2) cell differentiation, IgE class switching, and allergic inflammation. Dysregulated IL4R signaling is implicated in various conditions including asthma, atopic dermatitis, allergic diseases, and certain fibrotic disorders. The receptor also plays roles in alternative macrophage activation and tissue remodeling processes.
SSGJ-611 serves as the reference antibody for this biosimilar development, providing researchers with a cost-effective tool for investigating IL4R-mediated pathways. This antibody is valuable for studies examining Th2-driven immune responses, allergic disease mechanisms, cytokine receptor biology, and inflammatory signaling cascades. It supports research into understanding IL4R function in immune regulation and exploring therapeutic strategies targeting this pathway in allergic and inflammatory conditions.
There are currently no reviews for this product.